Chemiluminescence Immunoassay Market Size Is Estimated To Reach $10.8 Billion By 2027

The global chemiluminescence immunoassay market size is expected to reach a value of USD 10.8 billion by 2027, expanding at a CAGR of 7.3%, according to a new report by Grand View Research, Inc. High prevalence of chronic diseases, several advantages of chemiluminescence immunoassay (CLIA) technique and approval and launch of novel CLIA solutions are anticipated to be the major factors driving the market.

Key players in the market are implementing organic and inorganic growth strategies for the development, launch, and distribution of novel CLIA solutions. For instance, in February 2020, Snibe Diagnostic, a China-based immunoassay manufacturer received CE marking for its new MAGLUMI 2019-nCoV (SARS-CoV-2) IgM/IgG CLIA kits. Also, in January 2018, DiaSorin partnered with Germany-based Qiagen and added Qiagen’s QuantiFERON-TB diagnostic test portfolio to its LIAISON family of fully automated chemiluminescence immunoassay analyzers. Such initiatives by major players are anticipated to significantly support market growth.

Furthermore, the high prevalence of chronic diseases in key regions and increasing awareness about it in emerging economies is anticipated to upsurge the demand for its novel diagnostic solutions including chemiluminescence immunoassay. According to the data published by the American Cancer Society, in 2020 an estimated 1.8 million new cases of cancer are expected to be diagnosed in the U.S. and around 606,520 people will die due to the disease. In addition, as per the data published by the WHO in November 2019, HIV is a major global public health issue and around 37.9 million people around the globe are living with this disease.

Full Research Report On Chemiluminescence Immunoassay Market Visit Here: https://www.grandviewresearch.com/industry-analysis/chemiluminescence-immunoassay-market

Chemiluminescence Immunoassay Market Report Highlights

• The consumables segment dominated the product segment in 2019, owing to its high demand in therapeutic drug monitoring, endocrinology, and disease diagnosis
• The infectious disease segment is expected to command the largest market share in the application segment, owing to its high prevalence and launch of novel CLIA assays for infectious disease diagnosis
• In 2019, the hospitals' segment accounted for the largest market share owing to increasing hospitalizations with the rising prevalence of chronic diseases
• The U.S. is anticipated to be the most lucrative country in North America, owing to the developed healthcare infrastructure, high adoption of technologically advanced CLIA systems, and strong geographical presence of prominent players
• The emergence of local players in developing markets such as India and China is primarily driving the market in the Asia Pacific
• The high setup cost of automated chemiluminescence immunoassay systems is expected to be a major factor hindering the market.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/chemiluminescence-immunoassay-market/request/rs1

Chemiluminescence Immunoassay Market Segmentation

Grand View Research has segmented the global chemiluminescence immunoassay market on the basis of product, application, end-use, and region:

CLIA Product Outlook (Revenue, USD Million, 2016 - 2027)

• Instruments
• Automated
• Semi-automated
• Consumables
• Software & Services

CLIA Application Outlook (Revenue, USD Million, 2016 - 2027)

• Therapeutic Drug Monitoring
• Oncology
• Cardiology
• Endocrinology
• Infectious Disease
• Autoimmune Disease
• Others

CLIA End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Hospitals
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies
• Others

CLIA Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
• The U.S.
• Canada
• Europe
• Germany
• The U.K.
• Spain
• France
• Italy
• Russia
• Asia Pacific
• Japan
• China
• India
• South Korea
• Singapore
• Australia
• Latin America
• Brazil
• Mexico
• Argentina
• MEA
• South Africa
• Saudi Arabia
• UAE

List of Key Players of Chemiluminescence Immunoassay (CLIA) Market

• DiaSorin S.p.A.
• Abbott Laboratories
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Immunodiagnostic Systems
• Siemens Healthineers
• Beckman Coulter Inc.
• F. Hoffmann-La Roche AG
• Inova Diagnostics, Inc.
• Maccura Biotechnology Co., Ltd.
• Ortho Clinical Diagnostics

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com